Congenital muscular dystrophy with primary laminin α2 (Merosin) deficiency presenting as inflammatory myopathy

Annals of Neurology

Volumn 40, Issue 5, 1996, Pages 782-791

  Pegoraro, Elena ^a   Mancias, Pedro ^b   Swerdlow, Steven H ^c   Raikow, Radmila B ^c   Garcia, Carlos ^d   Marks, Harold ^e   Crawford, Thomas ^f   Carver, Virginia ^g   Di Cianno, Brad ^a   Hoffman, Eric P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^e NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; B LYMPHOCYTE; CLINICAL ARTICLE; CYTOPLASM VESICLE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFANT; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOPATHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 10544230641     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400515     Document Type: Article

References (44)

1. Dubowitz V. A colour atlas of muscle disorders in childhood. London: Wolfe Medical, 1989
2. Banker BQ. The congenital muscular dystrophies. In: Engel AG, Franzini-Armstrong C, eds. Myology, vol 1. New York: McGraw-Hill Book, 1994:1275-1289
3. Fukuyama Y, Kawazura M, Haruna H. A peculiar form of congenital progressive muscular dystrophy. Pediatr Univ Tokyo 1960;4:5-8
4. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev 1981;13:1-9
5. Toda T, Segawa M, Nomura Y, et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-q33. Nature Genet 1993;5:283-286
6. Santavuori P, Leisti J, Kruus S. Muscle, eye and brain disease: a new syndrome. Neuropediatrics 1977;8:553
7. Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev 1989;11:147-153
8. Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989;32: 195-210
9. Misugi N. Light and electron microscopic studies of congenital muscular dystrophy. Brain Dev 1980;2:191-199
10. Olney KK, Miller RG. Inflammatory infiltration in Fukuyama type congenital muscular dystrophy. Muscle Nerve 1983;6:75-77
11. Kohrman MH, Picchietti DL, Wollman R, Chelmicka-Schorr EE. A variant of Fukuyama congenital muscular dystrophy in a non-Japanese child. Pediatr Neurol 1986;2:290-293
12. Kinoshita M, Mishina M, Koya N. Ten years follow-up study of steroid therapy for congenital encephalomyopathy. Brain Dev 1986;8:280-284
13. Shevell M, Rosenblatt B, Silver K, et al. Congenital inflammatory myopathy. Neurology 1990;40:1111-1114
14. Fidzianska A, Goebel HH, Lenard HG, Heckman C. Congenital muscular dystrophy (CMD) - a collagen formative disease? J Neurol Sci 1982;55:79-90
15. Campbell KP, Kahl SD. Association of dystrophin and integral membrane glycoprotein. Nature 1989;338:259-262
16. Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991;66:1121-1131
17. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to extracellular matrix. Nature 1992;355: 696-702
18. Suzuki A, Yoshida M, Yamamoto H, Ozawa E. Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxyl-terminal domain. FEBS Lett 1992;308:154-160
19. Tinsley JM, Blake DJ, Zuelling RA, Davies KE. Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA 1994;91:8307-8313
20. Campbell KP. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995;80:675-679
21. Ehrig K, Leivo I, Argraves WS, et al. Merosin, a tissue-specific basement membrane protein, is a laminin like protein. Proc Natl Acad Sci USA 1990;87:3264-3268
22. Timpl R, Rohde H, Gehron Robey P, et al. Laminin a glycoprotein from basement membranes. J Biol Chem 1979;254: 9933-9937
23. Cooper AR, Kurkinen A, Taylor A, Hogan BLM. Studies on the biosynthesis of laminin by murine parietal endoderm cells. Eur J Biochem 1981;119:189-197
24. Voulteenaho R, Nissinen M, Sainio K, et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124:381-394
25. Tomé FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci Paris 1994;317:351-357
26. Hillaire D, Leclerc A, Fauré S, et al. Localization of merosinnegative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994;3:1657-1661
27. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genet 1995;11:216-218
28. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51:919-928
29. Hoffman EP, Kunkel LM, Angelini C, et al. Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology 1989;39:1011-1017
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
31. Pegoraro E, Schimke RN, Garcia C, et al. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin competent myonuclei. Neurology 1995;45:677-690
32. Glisin VR, Crkvenjadov R, Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 1974;13: 2633-2637
33. Zhou J, Hoffman EP. Pathophysiology of sodium channelopathies: studies of sodium channel expression by quantitative multiplex fluorescence polymerase chain reaction. J Biol Chem 1994;269:18563-18571
34. Duggan DJ, Fanin M, Pegoraro E, et al. Adhalinopathies: complete biochemical deficiency patients are 5% of childhoodonset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations. J Neurol Sci (in press)
35. Aberdam D, Galliano MF, Vailly J, et al. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma-2 subunit on nicein/kalinin (laminin-5). Nature Genet 1994;6:299-304
36. Sanes JR, Engvall E, Butkowski R, Hunter DD. Molecular heterogeneity of basal laminae: isoform of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 1990;111:1685-1699
37. Engvall E. Laminin variants: why, where and when? Kidney Int 1993;43:2-6
38. Leivo I, Engvall E. Merosin, a protein specific for basement membrane of Schwann cells, striated muscle and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 1990;85:1544-1548
39. Sewry CA, Chevallay M, Tomé FMS. Expression of laminin subunits in human fetal skeletal muscle. Histochem J 1995;27: 497-504
40. Engvall E, Earwicker D, Haaparanta T, et al. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1990;1:731-740
41. Silverstein AM, Hirsh DK, Trobe JD, Gebarski SS. MR imaging of the brain in five members of a family with Paelizeus-Merzbacher disease. Am J Neuroradiol 1990;11:495-499
42. Shorer Z, Philpot J, Muntoni F, et al. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol 1995;10:472-475
43. Bernard A, Lauwerys R, Mahieu P, Foidart JM. Anti basement membrane antibodies in the serum of healthy subjects. N Engl J Med 1986;314:1456-1457
44. Gabrielli A, Leoni P, Danieli G, et al. Antibodies against galactosyl (α → 3) galactose in connective tissue diseases. Arthritis Rheum 1991;34:375-376